Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with singlephoton emission computerized tomography imaging (original) (raw)

This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. Dismiss this warning

Douglas W. Laske

Douglas W. Laske Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Douglas W. Laske in
Current site
Google Scholar
PubMed

Close

M.D.

,

Paul F. Morrison

Paul F. Morrison Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Paul F. Morrison in
Current site
Google Scholar
PubMed

Close

Ph.D.

,

Daniel M. Lieberman

Daniel M. Lieberman Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Daniel M. Lieberman in
Current site
Google Scholar
PubMed

Close

M.D.

,

Mark E. Corthesy

Mark E. Corthesy Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Mark E. Corthesy in
Current site
Google Scholar
PubMed

Close

M.D.

,

James C. Reynolds

James C. Reynolds Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by James C. Reynolds in
Current site
Google Scholar
PubMed

Close

M.D.

,

Patricia A. Stewart-Henney

Patricia A. Stewart-Henney Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Patricia A. Stewart-Henney in
Current site
Google Scholar
PubMed

Close

C.N.M.T.

,

Sung-Soo Koong

Sung-Soo Koong Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Sung-Soo Koong in
Current site
Google Scholar
PubMed

Close

M.D.

,

Alex Cummins

Alex Cummins Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Alex Cummins in
Current site
Google Scholar
PubMed

Close

M.A.

,

Chang H. Paik

Chang H. Paik Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Chang H. Paik in
Current site
Google Scholar
PubMed

Close

Ph.D.

, and

Edward H. Oldfield

Edward H. Oldfield Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke; Biomedical Engineering and Instrumentation Program, National Center for Research Resources; and Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Search for other papers by Edward H. Oldfield in
Current site
Google Scholar
PubMed

Close

M.D.

View More View Less

Restricted access

Purchase Now

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

Purchase Now

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

Print or Print + Online Sign in

✓ High-flow interstitial infusion into the brain, which uses bulk fluid flow to achieve a relatively homogeneous drug distribution in the extracellular space of the brain, has the potential to perfuse large volumes of brain. The authors report reproducible long-term delivery of 111In—diethylenetriamine pentaacetic acid—apotransferrin (111In-DTPA-Tf) (molecular mass 81 kD) to Macaca mulatta brain and monitoring with single-photon emission computerized tomography (SPECT). The 111In-DTPA-Tf was infused at 1.9 µl/minute over 87 hours into the frontal portion of the centrum semiovale using a telemetry-controlled, fully implanted pump. On Days 1, 3, 4, 8, 11, and 15 after beginning the infusion, planar and SPECT scans of 111In-DTPA-Tf were obtained. Spread of protein in the brain ranged from 2 to 3 cm and infusion volumes ranged from 3.9 to 6.7 cm3. Perfusion of over one-third of the white matter of the infused hemisphere was achieved. From brain SPECT images of 99mTc—hexamethylpropyleneamine oxime, which was administered intravenously before each 111In scan, the authors also found that blood perfusion in the infused region was reduced by less than 5% relative to corresponding noninfused regions. Histological examination at 30 days revealed only mild gliosis limited to the area immediately surrounding the needle tract. These findings indicate that long-term interstitial brain infusion is effective for the delivery of drugs on a multicentimeter scale in the primate brain. The results also indicate that it should be possible to perfuse targeted regions of the brain for extended intervals to investigate the potential utility of neurotrophic factors, antitumor agents, and other materials for the treatment of central nervous system disorders.